Most life sciences and biopharma hedge funds started 2026 on the back foot, giving up ground in January after one of the strongest years on record for the sector with the pull-back coming despite a 2.5% gain in the Nasdaq
Singapore sovereign wealth fund GIC has redeemed around $250m from Jain Global, less than two years after backing one of the hedge fund industry’s largest-ever launches, according to a report by The Business Time citing sources familiar with the matter.
Leading macro hedge funds, including Rokos Capital Management and Pharo Management, delivered strong gains in January as heightened volatility across global markets created fertile conditions for discretionary traders, according to a report by Bloomberg.
Quantitative hedge fund manager Qube Research & Technologies has expanded assets in its China-focused long-only equity strategy more than tenfold over the past year, as global investors return to the country’s equity markets, according to a report by Bloomberg.
TabCap Investment Management, a hedge fund that eschewed the recent boom in the private credit sector is thriving as its focus on investments in liquid credit instruments delivers strong returns, according to a report by Bloomberg.
Brevan Howard’s Minal Bathwal has emerged as one of the most consistent and profitable global macro managers in the hedge fund industry, delivering uninterrupted annual gains since he began managing capital in 2008, according to report by Bloomberg citing unnamed
Singapore-based systematic quantitative hedge fund Quantedge Capital kicked off 2026 with strong performance, posting 10% gains in January, its best monthly return since November 2024, according to a report by Financial News London.
Macro hedge funds started 2026 with robust performance, with Haidar Capital Management leading, as managers capitalises on market volatility, while multi-strategy giants delivered steady returns, according to a report by Bloomberg.
ARR Investment Partners, a $60m London-based investment advisor that has been backed by over 70 investors via separately managed accounts, including Fasanara Open Quant Fund and a major New York-based multi-strategy investment firm, has launched a Cayman-domiciled global long-short equity
Hedge fund performance strengthened sharply in January, led by macro strategies that benefited from pronounced volatility across commodities and energy markets, according to the latest data from data from hedge fund indexation and analysis specialist HFR.
